APA

Schrörs B., Lübcke S., Lennerz V., Fatho M., Bicker A., Wölfel C., Derigs P., Hankeln T., Schadendorf D., Paschen A. & Wölfel T. (20180305). HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model. : Oncotarget.

Chicago

Schrörs Barbara, Lübcke Silke, Lennerz Volker, Fatho Martina, Bicker Anne, Wölfel Catherine, Derigs Patrick, Hankeln Thomas, Schadendorf Dirk, Paschen Annette and Wölfel Thomas. 20180305. HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model. : Oncotarget.

Harvard

Schrörs B., Lübcke S., Lennerz V., Fatho M., Bicker A., Wölfel C., Derigs P., Hankeln T., Schadendorf D., Paschen A. and Wölfel T. (20180305). HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model. : Oncotarget.

MLA

Schrörs Barbara, Lübcke Silke, Lennerz Volker, Fatho Martina, Bicker Anne, Wölfel Catherine, Derigs Patrick, Hankeln Thomas, Schadendorf Dirk, Paschen Annette and Wölfel Thomas. HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model. : Oncotarget. 20180305.